Inhibition of the Early-Stage Cross-Amyloid Aggregation of Amyloid-β and IAPP via EGCG: Insights from Molecular Dynamics Simulations-Reference-Cited by-同舟云学术

Inhibition of the Early-Stage Cross-Amyloid Aggregation of Amyloid-β and IAPP via EGCG: Insights from Molecular Dynamics Simulations

Published:2024-07-03 Issue:28 Volume:9 Page:30256-30269
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Srivastava Amit¹^ORCID,Al Adem Kenana²³,Shanti Aya⁴,Lee Sungmun⁵⁶^ORCID,Abedrabbo Sufian¹^ORCID,Homouz Dirar¹^ORCID

Affiliation:

1. Department of Physics, Khalifa University of Science and Technology, Abu Dhabi 127788, UAE

2. Chair of Biological Imaging, Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich 81675, Germany

3. Institute of Biological and Medical Imaging, Helmholtz Zentrum München, Neuherberg 81675, Germany

4. Department of Biological Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, UAE

5. Department of Biomedical Engineering and Healthcare Engineering Innovation Center, Khalifa University of Science and Technology, Abu Dhabi 127788, UAE

6. Khalifa University’s Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, UAE

Funder

Khalifa University of Science, Technology and Research

Government of Abu Dhabi

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.4c00500

Reference66 articles.

1. The amyloid state and its association with protein misfolding diseases

2. Protein Misfolding, Functional Amyloid, and Human Disease

3. Prince, M.; Comas-Herrera, A.; Knapp, M.; Guerchet, M.; Karagiannidou, M. World Alzheimer Report: Improving healthcare for people living with dementia: Coverage, Quality and costs now and in the future Doctoral dissertation, 2016.

4. Type 2 diabetes mellitus

5. Type 2 diabetes as a protein misfolding disease